Several publications indicate that a high level of GATA4 expression is associated with various outcomes dependent on cancer type; for example, a survival analysis indicated that a high GATA4 expression level is significantly correlated with better OS in second clinical-stage ovarian cancer. Here, GATA4 is linked to cancer.